Post-IPO Equity - Marinus Pharmaceuticals - Apr 4, 2022 Funding Round Profile - Cointime

Bitcoin $78,704.25 +2.87%
Ethereum $3,173.14 +4.38%
BNB $629.92 -0.16%
Optimism $1.66 +0.96%
Arbitrum $0.62 +2.36%
Solana $205.48 +2.26%
Polygon $0.40 +3.15%
Cosmos $4.95 +4.27%
Avalanche $31.39 +6.88%

Bitcoin $78,704.25 +2.87%
Ethereum $3,173.14 +4.38%
BNB $629.92 -0.16%
Optimism $1.66 +0.96%
Arbitrum $0.62 +2.36%
Solana $205.48 +2.26%
Polygon $0.40 +3.15%
Cosmos $4.95 +4.27%
Avalanche $31.39 +6.88%

Marinus Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 1.23M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Mar 31, 2022	Post-IPO Debt	$ 30M	Oaktree Capital Management	Detail
May 17, 2021	Post-IPO Debt	$ 45M	Oaktree Capital Management	Detail
May 29, 2020	Post-IPO Equity	$ 46M		Detail
Sep 14, 2017	Post-IPO Equity	$ 40.30M	Bain Capital Life Sciences	Detail
May 3, 2009	Series B	$ 20M	Canaan Partners,Domain Associates,etc.	Detail
Jan 7, 2013	Series C	$ 21M	Canaan Partners,Domain Associates,etc.	Detail
Oct 25, 2005	Series A	$ 29.40M	Canaan Partners,Domain Associates,etc.	Detail
Dec 19, 2012	Series Unknown	$ 11.43M	RMI Partners	Detail
Dec 10, 2019	Post-IPO Equity	$ 70M	Bain Capital Life Sciences	Detail
Jul 21, 2014	IPO	$ 45M		Detail